ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway

BACKGROUND: ALX4 is a paired-like homedomain transcription factor mainly expressed in the mesenchymal compartment of variety of developing tissues, but its functions, regulation mechanisms and clinical values in breast cancer remains unclear. METHODS: The expression of ALX4 in breast cancer cell lin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Yang, Juntang, Han, Fei, Liu, Wenbin, Chen, Hongqiang, Hao, Xianglin, Jiang, Xiao, Yin, Li, Huang, Yongsheng, Cao, Jia, Zhang, Huidong, Liu, Jinyi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5706407/
https://ncbi.nlm.nih.gov/pubmed/29183346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0643-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados